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The mechanisms controlling the activity of ornithine decarboxylase (ODC) are complex and only partly 
understood. This study shows that ODC can exist as two different aggregation states, that differ in catalytic 
activity, the dimeric form being active and the monomeric form inactive. While L-ornithine shifts the asso- 
ciation-dissociation equilibrium to the dimeric form, salts produce an opposite effect leading to subunit dis- 
sociation. a-DFMO, an enzyme-activated irreversible inhibitor of ODC, does not react with the monomeric 
form and therefore the influence of substrate and salts on the aggregation equilibrium must be taken into 
account in titration experiments with a-DFMO of the total amount of ODC in tissue preparations. 
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1. INTRODUCTION 
Ornithine decarboxylase (L-ornithine carboxy- 
lyase, EC 4.1.1.17) is a pyridoxal 5’-phosphate 
requiring-enzyme which catalyses the formation of 
putrescine from L-ornithine, the first and rate- 
limiting step in the biosynthesis of polyamines 
[l-3]. This enzyme, which is considered to play an 
important role in the control of cell growth, pro- 
liferation and differentiation [4], exhibits an ex- 
tremely short half-life [5] and its activity is affected 
by a great variety of agents. To account for the 
rapid changes in its activity, several in vivo 
regulatory mechanisms have been reported, such 
as post-translational modifications [6,7] and 
regulatory proteins [8,9]. The existence of cryptic 
or latent forms of the enzyme has also been sug- 
gested [lo]. In most cases, the changes in activity 
are correlated with the amount of enzymatic pro- 
tein, as shown by radioimmunoassay titration [l l] 
or by means of radiolabelled a-DFMO, a suicide 
substrate of ODC [l 1,121. 
Abbreviations: ODC, ornithine 
DFMO, cr-difluoromethylornithine 
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Although the activity of ODC is probably not 
mainly regulated by any low molecular mass effec- 
tors at physiological level, in vitro experiments 
have shown that ODC activity is also affected by 
a variety of chemical agents such as salts [13,14], 
polyanions [ 151 or phospholipids [ 161. Moreover, 
the ionic strength influences the aggregation state 
of the enzyme, since different forms have been 
observed in gel-filtration experiments to depend on 
the ionic conditions [ 13,171. This report shows that 
the enzyme occurs basically as an equilibrium be- 
tween a monomeric inactive form and a dimeric ac- 
tive form. The aggregation state of ODC can be 
shifted in opposite directions by salts and L- 
ornithine. The inactivity of the monomer, shown 
here, and the reversibility of the equilibrium, are 
very important points to be taken into account 
when irreversible inactivation or affinity labelling 
by suicide substrates, such as a-DFMO, are carried 
out. 
2. EXPERIMENTAL 
DL-[1-i4C]Ornithine (57 mCi/mmol) was ob- 
tained from Radiochemical Centre (Amersham, 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
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England). Sephadex G-200 and DEAE-Sephadex 
A-50 were purchased from Pharmacia (Uppsala). 
a-DFMO was a generous gift from Merrell Inter- 
national (Strasbourg, France). Unlabelled L- 
ornithine, pyridoxal 5 ’ -phosphate, dithiothreitol, 
EDTA, thioacetamide, trypsinogen, bovine serum 
albumin and catalase were purchased from Sigma 
(London, England). All other chemicals and 
reagents were of analytical grade. 
ODC was obtained from liver cytosol of adult 
Wistar rats treated with thioacetamide (150 mg/ 
kg) 24 h before killing. The enzyme was partially 
purified by ammonium sulphate fractionation, 
ion-exchange chromatography on DEAE- 
Sephadex and gel permeation chromatography on 
Sephadex G-200 [ 131. 
The activity of ODC was assayed by measuring 
the rate of 14COz evolved from L-[1-r4C]ornithine. 
The assay mixture contained 25 mM sodium 
phosphate buffer (pH 7.2), 2 mM dithiothreitol, 
0.1 mM EDTA, 0.1 mM pyridoxal phosphate 
(buffer A), variable amount of L-ornithine and 
50 pl enzyme solution in a total volume of 200 ~1.. 
The reaction was carried out at 37°C in tubes 
sealed with rubber stoppers suspending paper filter 
discs containing hyamine hydroxide. After 1 h the 
reaction was stopped by the addition of 0.5 ml of 
3 M citric acid. After 45 min, paper discs were 
removed and counted on toluene based scintilla- 
tion mixture. Activity was expressed in nmol CO2 
released/h. 
3. RESULTS 
The activity of ODC decreases considerably by 
increasing salt concentration in the assay mixture. 
This effect was not dependent on the nature of the 
salt, although slight variations were observed 
(fig. 1) and sodium chloride was used as a standard 
for increasing the ionic strength in the enzyme 
media. The double-reciprocal plot of fig.2 shows 
that the apparent K, of the enzyme for L-ornithine 
increases with NaCl concentration, but Vmax re- 
mains constant. This indicates that NaCl acts as a 
competitive inhibitor of ODC. However, NaCl 
cannot be considered as a classical competitive in- 
hibitor, but rather that NaCl and L-ornithine exert 
opposite effects on ODC activity. The fact 
reported by Kitani and Fujisawa [13], that salts 
produce subunit dissociation of the enzyme, and 
I I I I I I 
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Fig. 1. Inhibition of ODC activity by salt concentration. 
The assay medium was 15.6 PM [I-‘4C]ornithine and 
variable concentration (M) of salt in buffer A. (0) 
NaCI, (A) KNO3. 
0.05 0.1 l/ml()N 
Fig.2. Lineweaver-Burk plot of the inhibition of ODC 
activity by NaCl. The assay medium was 15.6rM 
[ l-14C]ornithine and variable concentrations of 
unlabelled L-ornithine and NaCl in buffer A. (0) 
Control. NaCI: 0.05 M (0), 0.1 M (A) and 0.2 M (0). 
the above results similar to those reported by these 
authors, can be explained assuming that ODC ex- 
ists as an equilibrium of dimeric and monomeric 
forms, and that NaCl enhances the dissociation 
while L-ornithine decreases the effect produced by 
the salt. 
To assess the above mentioned hypothesis, 
represented by the scheme, 
NaCl 
ODC dimer + ODC monomer 
L-Orn 
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the molecular mass of the enzyme was determined 
by gel permeation chromatography on a calibrated 
column of Sephadex G-200, under 3 different sets 
of conditions: I, in the absence of NaCl and L- 
ornithine; 2, in the presence of 0.25 M NaCl and 
the absence of L-ornithine, and 3, in the presence 
of 0.25 M NaCl and 0.1 mM L-ornithine. Fig.3 
shows the molecular mass determined for ODC 
under the above mentioned conditions. In the 
absence of NaCl and L-ornithine the apparent Mr 
was approx. 100000, but in the presence of 0.25 M 
NaCl the A4 was 55000. When the column was 
equilibrated and eluted with buffer containing 
both 0.25 M NaCl and 0.1 mM L-ornithine the 
elution profile of enzyme activity exhibited a broad 
peak, but the fraction with highest activity again 
indicated an M, of approx. 100000. 
The reversibility of the equilibrium was verified 
since samples of enzyme incubated with high NaCl 
concentrations howed the same activity after dilu- 
tion of salt concentration in the assay mixture as 
samples not preincubated. 
The parallel inhibitory and disaggregating ef- 
fects of NaCl clearly show that the monomer is less 
active than the dimer. In turn, chromatography 
shows that at NaCl concentration about 0.25 M or 
higher the main form of ODC is the monomer. The 
1 
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Table 1 
Pre-treatment Activity 070 
(nmoi CO2 A I-I-‘) inactivation 
(a) None 
(b) 1 M NaCl 
(c) 1 PM a-DFMO 
(d) 1 M NaCl plus 
1 fiM wDFMO 
1.49 
1.48 
0.36 16 
1.50 
Samples of 100~1 of enzyme were incubated for 5 h in 
buffer A (control, a), 1 M NaCl (b), 1 pM cu-DFMO tc) 
or 1 M NaCl and 1 PM a-DFMO (d). Activity was 
determined by adding 25 ,ul preincubated enzyme to the 
assay media containing 31 pM L-[l-‘4C]ornithine and 
69 ,uM L-ornithine. All assays were normalized to reach 
final concentration of (Y-DFMO and NaCl of 0.2pM 
and 0.2 M, respectively 
activity of this form cannot be clearly determined 
since the presence of L-ornithine enhances the for- 
mation of the more active dimeric form. To test 
the activity of the monomer we studied the inac- 
tivation of ODC by means of the suicide substrate 
analogue cu-DFMO. It follows that conditions 
decreasing the enzyme activity will also prevent the 
inactivation of this enzyme. Samples of enzyme 
were preincubated under different conditions: 
1 PM cu-DFMO; 1 PM cu-DFMO plus 1 M NaCl, 
and in the absence of both. After 5 h of preincuba- 
tion, the activity was determined from aliquots in 
the presence of L-ornithine, being all activity 
measurements normalized to the activity of control 
reaction containing identical concentration of (Y- 
DFMO and NaCl. The concentration of these com- 
pounds in the assay mixture was 0.2 ,uM and 
0.2 M, respectively. Table 1 shows that preincuba- 
tion with 1 M NaCl does not affect, in a time 
dependent way, the activity of ODC. The prein- 
cubation of ODC with 1 ,uM a-DFMO con- 
siderably decreased the enzyme activity. However, 
when the enzyme was preincubated with 1 ,uM cy- 
DFMO in the presence of 1 M NaCl, no inactiva- 
tion, at all, could be detected, Therefore, ODC in 
the presence of 1 M NaCl and the absence of the 
substrate, L-ornithine, is completely inactive and 
consequently it cannot be inactivated by the suicide 
substrate, since this inactivation depends on the 
presence of active enzyme. 
Fig.3. Determination of M, of ODC by gel-permeation 
in Sephadex G-200. The column (1.2 x 28 cm) was 
equilibrated with 3 different conditions as detailed in the 
text. Standard calibration proteins: 1, trypsinogen; 2, 
bovine serum albumin; 3, catalase. Monomer: buffer A 
containing 0.25 M NaCl (condition 2). Dimer: buffer A 
(condition 1). Buffer A containing 0.25 M NaCl and 
0.1 mM L-ornithine (condition 3). 
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4. DISCUSSION 
The mechanisms controlling ornithine decarbox- 
ylase activity seem to be complex and partially 
understood. Several modified forms of the enzyme 
have been reported, including phosphorylated [7] 
and transamidated forms [6], and the existence of 
an equilibrium between active and cryptic forms of 
ODC has also been suggested [lo]. Moreover, dif- 
ferent investigators have observed multiple &forms 
of ODC after fractionation by gel permeation 
chromatography [13,17], but the physiological 
significance of these forms remains unknown. 
Salts are reported to be strong effecters of ODC 
activity both in vitro [13,14] and in vivo conditions 
[20,21]. Our results show that ODC activity is 
greatly dependent on ionic strength, and that salts 
affect the aggregation state of the enzyme. Kitani 
and Fujisawa [13] showed that ionic strength in- 
creases the iu, for L-ornithine and causes subunit 
dissociation of the rat liver enzyme. ODC from 
Phyconayces is also inhibited by salts [14] and an 
equilibrium between dimeric and monomeric 
forms affected by salts and polyamines has been 
described for ODC of ~~y~~~~ ]17]. However, 
no correlation between the changes in activity and 
aggregation state has been clearly stated. The 
results presented in this paper indicate that the en- 
zyme can exist as two different states, dimeric or 
monomeric. Two important factors, L-ornithine 
and ionic strength, have an opposite effect, the lat- 
ter favouring the dissociation to the monomeric 
form and the substrate preventing the dissociation. 
So, NaCl acts as a competitive inhibitor. 
This mechanism explains the experimental data 
only if the monomeric form is inactive. This 
hypothesis cannot be simply tested by measuring 
ODC activity since the presence of substrate shifts 
the equilibrium to the dimeric active form. To 
elude this difficulty, the activity was tested in the 
absence of substrate by using a potent suicide in- 
hibitor, CPDFMO, that acts only on the active en- 
zymic form. The absence of inactivation of ODC 
at high NaCl concentration in the presence of CP 
DFMO demonstrates that ODC monomer is 
devoided of catalytic activity. 
The relationship between activity and quater- 
nary structure of enzymes as well as the participa- 
tion of substrates and products in the association- 
dissociation equilibria has been reported ]18,19]. 
Although this relation could be significant for the 
regulation of intracellul~ activity in some en- 
zymes, the implication of this mechanism in the 
control of intracellular ODC activity cannot be 
evaluated prior. Experiments using different 
types of cell culture have shown that ODC activity 
is greatly affected by ionic content of the media 
[20,21]. If such equilibrium occurs under 
physiological conditions, its relative importance in 
the regulation of ODC activity could be related to 
the existence of two forms of different metabolic 
stability rather than to forms of different catalytic 
activity, since it is known that the structure can 
play an important role in the process of enzyme 
degradation, which is an important but unknown 
event in the regulation of the turnover of this 
enzyme. 
On the other hand, the existence of inactive 
forms of ODC readily convertible in active forms 
by either L-ornithine or decreasing ionic strength, 
can be of interest in experiments based on the 
treatment of ODC with (Y-DFMO. L-Ornithine 
must not be present in the labelling mixture since 
it can compete with (u-DFMO for the enzyme. The 
relative amount of monomeric forms to the total 
enzyme protein can be increased dramatically by 
the ionic strength under conditions in which L- 
ornithine is not present. wDFMO produces inhibi- 
tion of growth and replication and has been used 
in cancer chemotherapy [22]. Labelled ar-DFMO 
has proved to be particularly useful in enzymatic 
studies because of its specific covalent binding to 
ODC. The low percentage of ODC resistant o cy- 
DFMO reported in some preparations ]23] could 
be related to this ‘cryptic’ monomeric form of 
ODC. Thus, the wide variation in sensitivity of 
ODC to a-DFMO depending on the state of the en- 
zyme would be taken into account to maximize the 
usefulness of this drug in medicine and 
biochemical research purposes. 
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